Company name Envision Healthcare Corporation
Stock symbol EVHC
Class period March 2, 2015-July 21, 2017
Lead plaintiff deadline October 3, 2017
Court Middle District of Tennessee
Status Under Investigation

NEW YORK, August 7, 2017 – Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Middle District of Tennessee on behalf of all persons or entities who purchased or otherwise acquired Envision Healthcare Corporation (NYSE: EVHC) securities between March 2, 2015 and July 21, 2017 (the “Class Period”).  Investors have until October 3, 2017 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

On July 24, 2017, The New York Times reported that physicians associated with a subsidiary of Envision, EmCare Holdings, Inc., were disproportionately likely to engage in “surprise billing,” which occurs when patients go to in-network hospitals, but are treated by out-of-network doctors and then billed at higher rates.  Following this news, EVHC fell $2.33 per share on July 24, 2017, or over 3.7%, to close at $60.28 per share.

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (i) EmCare routinely arranged for patients who sought treatment at in-network facilities to be treated by out of-network physicians; (ii) EmCare accordingly billed these patients at higher rates than if the patients had received treatment from in-network physicians; (iii) the Company’s statements attributing EmCare’s Class Period growth to other factors were therefore false and/or misleading; (iv) Envision’s EmCare revenues were likely to be unsustainable after the foregoing conduct came to light; and (v) as a result of the foregoing, Envision’s public statements were materially false and misleading at all relevant times.

If you purchased or otherwise acquired Envision Healthcare securities during the Class Period and suffered a loss or continue to hold shares purchased prior to the Class Period, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.

Join the action by filling out the form below

First name*

Last name*

City, state ZIP code*

Email address*

Daytime phone*

Evening phone

Purchase Date*

No. of Shares*

Purchase Price*

Purchase Date

No. of Shares

Purchase Price

Join action?*
YesNo


Call to provide more information: Tel: (212) 308-5858

Please list below any additional transactions in this security:

Additional comments

The submission of this form does not create an attorney-client relationship, nor any obligation on the part of Bragar Eagel & Squire, P.C., or you to file a legal action. Any information you submit will be maintained as confidential. If Bragar Eagel & Squire, P.C., in its sole discretion, believes that you might be an appropriate class representative, Bragar Eagel & Squire, P.C., will contact you to discuss the matter and to determine whether to establish an attorney client relationship.